ReviewMolecules (Basel, Switzerland)2024
Emerging Fluorescent Nanoparticles for Non-Invasive Bioimaging.
Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Potential of Silver Nanoparticles in Imaging Diagnostics and Image-Guided Applications: A Narrative Review.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Fluorescence Analysis of Local Microenvironments in Polymer Films Using Solvatochromic Dyes.Sensors (Basel, Switzerland) · 2026Article
- Applications of Nanobiotechnology in Medicine.Life (Basel, Switzerland) · 2026Review
- Advances in NIR-II Fluorescent Nanoprobes: Design Principles, Optical Engineering, and Emerging Translational Directions.Micromachines · 2025Review
- Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy-Implications for Radiopharmaceutical Repurposing (Beyond Oncology).Pharmaceutics · 2025Review
- Advances in Ultrasmall Inorganic Nanoparticles for Nanomedicine: From Diagnosis to Therapeutics.ACS applied materials & interfaces · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fluorescence-based techniques have great potential in the field of bioimaging and could bring tremendous progress in microbiology and biomedicine. The most essential element in these techniques is fluorescent nanomaterials. The use of fluorescent nanoparticles as contrast agents for bioimaging is a large topic to cover. The purpose of this mini-review is to give the reader an overview of biocompatible and biodegradable fluorescent nanoparticles that are emerging nanomaterials for use in fluorescent bioimaging. In addition to the biocompatibility of these nanomaterials, biodegradability is considered a necessity for short-term sustainable bioimaging. Firstly, the main requirements for bioimaging are raised, and a few existing fluorescent nanoprobes are discussed. Secondly, a few inert biocompatible fluorescent nanomaterials for long-term bioimaging that have been, to some extent, demonstrated as fluorescent probes are reviewed. Finally, a few biocompatible and biodegradable nanomaterials for short-term bioimaging that are evolving for bioimaging applications are discussed. Together, these advancements signal a transformative leap toward sustainability and functionality in biomedical imaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.